Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 864

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 7A
Chunk 864
---
 of these instruments. Set out below are the Company’s financial instruments that are required to be remeasured at fair value on a recurring basis in the fair value hierarchy as of December 31, 2024 and 2023:   December 31, 2024   Level 1  Level 2  Level 3  Total Marketable securities – trading securities            Commercial paper $-  $-  $-  $- Asset-backed securities  -   -   -   - Corporate debt  -   -   -   - U. S. Government instruments  -   -   -   -   $-  $-  $-  $-    December 31, 2023   Level 1  Level 2  Level 3  Total Marketable securities – trading securities            Commercial paper $-  $4,654  $-  $4,654 Asset-backed securities  -   974   -   974 Corporate debt  -   1,482   -   1,482 U. S. Government instruments  -   501   -   501   $-  $7,611  $-  $7,611  Stock-Based Compensation  The Company utilizes the Black-Scholes option pricing model to estimate the fair value of stock option awards at the date of grant, which requires the input of highly subjective assumptions, including expected volatility and expected life. Changes in these inputs and assumptions can materially affect the measure of estimated fair value of our share-based compensation. These assumptions are subjective and generally require significant analysis and judgment to develop. When estimating fair value, some of the assumptions will be based on, or determined from, external data and other assumptions may be derived from our historical experience with stock-based payment arrangements. The appropriate weight to place on historical experience is a matter of judgment, based on relevant facts and circumstances. The Company accounts for forfeitures of stock options as they occur. Net Loss per Share of Common Stock Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of Common Stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of Common Stock plus the effect of dilutive potential common